Showing 12 of 18 posts with this tag
Waterdrop, a platform dedicated to insurance and healthcare service, today reported a net operating revenue YoY increase of 38.0% to 939.4 million yuan ($145.5 million) in the second quarter of this year.
Chinese medical data company LinkDoc Technology filed paperwork on Monday to list shares in the US, as China’s digital healthcare industry continues to grow in the wake of the coronavirus pandemic.
According to information disclosed by the Hong Kong Stock Exchange, Richard Liu, founder of e-commerce giant JD.com, has recently sold 8.84 million shares in firm subsidiary JD Health, cashing out about HK $440 million.
EV battery maker SVolt Energy Technology bags a hefty Series A round, luxury brand group Ushopal raises another $100 million to fund expansion plans, and healthcare investor OrbiMed closes a new Asia fund.
Chinese e-commerce retailer JD.com, Inc. is planning to spin off and list its health unit on the Hong Kong stock exchange, the New York-listed company said Monday.
News emerged recently that the Xiaohe Health app owned by Beijing-based tech giant ByteDance will be shut down, and the company's Wukong Q&A app, which was shut down two years ago, will be launched again. However, ByteDance has denied both claims.
JD Health, the healthcare branch of Chinese e-commerce and supply chain giant JD.com Tuesday announced the launch of its online health care service “Family Doctor” based on “internet+healthcare” model.
On Friday, Xianghubao, a mutual aid health-care platform under Ant Group, announced its latest mutual aid list 10 days after it announced a closure notice.
Chinese online-to-offline (O2O) medicine platform Dingdang Health has raised $220 million in its latest financing round led by TPG Capital Asia, the company announced on Tuesday.
Dingdang Health, a digital medical services provider, was officially listed on the main board of the Hong Kong Stock Exchange with "9886" as the ticker symbol on September 14.
China's National Medical Products Administration granted approval on August 31 to Tencent Healthcare (Shenzhen) Co., Ltd. for the registration of its innovative medical device.
Recent weeks have seen soaring COVID-19 cases across China, pushing many people to various domestic health platforms in an attempt to purchase coveted antiviral medication and fever-reduction pills.